Skip to main content
. 2023 Jun 16;16(6):888. doi: 10.3390/ph16060888

Figure 1.

Figure 1

Previously described potent inhibitors of tubulin polymerization (CA-4 (I), phenstatin (II), phenothiazines (III,IV)) [4,5] and of human farnesyltransferase (Lonafarnib (SCH66336) (V) [13] and FTI-277 (VI) [14]) investigated as anticancer compounds.